Treatment of congestive heart failure - A neuroendocrine disorder

Journal of Small Animal Practice

Volumn 44, Issue 4, 2003, Pages 154-160

  Martin, M W S ^a  

^a Veterinary Cardiorespiratory Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROHORMONE; NITROPRUSSIDE SODIUM; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; ENDOTHELIN; MEMBRANE METALLOENDOPEPTIDASE; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT; VETERINARY DRUG;

ADRENERGIC SYSTEM; CARDIOLOGY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; HUMAN; LICENSING; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VETERINARY MEDICINE; ANIMAL; ANIMAL DISEASE; CONTROLLED CLINICAL TRIAL; DOG; DOG DISEASE; DRUG ANTAGONISM; NEUROSECRETION; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOTONIC AGENTS; DIURETICS; DOG DISEASES; DOGS; ENDOTHELINS; HEART FAILURE, CONGESTIVE; HUMANS; NEPRILYSIN; NEUROSECRETORY SYSTEMS; RANDOMIZED CONTROLLED TRIALS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS; VETERINARY DRUGS;

EID: 0038529540     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2003.tb00137.x     Document Type: Review

References (41)

1. AUSLENDER, M. (2000) Pathophysiology of pediatric heart failure. Progress in Pediatric Cardiology 11, 175-184
2. BENCH STUDY (1999) The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long term clinical trial. Journal of Veterinary Cardiology 1, 7-18
3. BOZKURT, B., KRIBBS, S. B., CLUBB, F.-J. JR., MICHAEL, L. H., DIDENKO, V. V., HORNSBY, P. J., SETA, Y., ORAL, H., SPINALE, F. G. & MANN, D. L. (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodelling in rats. Circulation 97, 1382-1391
4. CIBIS-II STUDY (1999) The Cardiac Insufficiency Bisoprolol Study II: a randomised trial. Lancet 353, 9-13
5. CLELAND, J. G. F. & SWEDBERG, K. (1998) Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. Lancet 351, 1657-1658
6. CODY, R. J., ATLAS, S. A., LARAGH, J. H., KUBO, J. H., COVIT, A. B., RYMAN, K. S., SHAKNOVICH, A., PONDOLFINO, K., CLARK, M. & CAMARGO, M. J. (1986) Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. Journal of Clinical Investigation 78, 1362-1374
7. COHN, J. N., JOHNSON, G., ZIESCHE, S., COBB, F., FRANCIS, G., TRISTANI, F., SMITH, R., DUNKMAN, W. B., LOEB, H. & WONG, M. (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. New England Journal of Medicine 325, 303-310
8. COLUCCI, W. S., ELKAYAM, U., HORTON, D. P., ABRAHAM, W. T., BOURGE, R. C., JOHNSON, A. D., WAGONER, L. E., GIVERTZ, M. M., LIANG, C., NEIBAUR, M., HAUGHT, H. & LEJEMTEL, T. H. (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. New England Journal of Medicine 343, 246-253
9. CONSENSUS TRIAL STUDY GROUP (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New England Journal of Medicine 316, 1429-1435
10. COVE STUDY (1995) Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the Cooperative Veterinary Enalapril Study Group. Journal of Veterinary Internal Medicine 9, 243-252
11. DALLA-VOLTA, S. (1995) Safety and efficacy study of delapril versus enalapril in patients with congestive heart failure. American Journal of Cardiology 75, 44F-49F
12. DIGITALIS INVESTIGATION GROUP (1997) The effect of digoxin on mortality and morbidity in patients in heart failure. New England Journal of Medicine 336, 525-533
13. ELKAYAM, U., KHAN, S., MEHBOOB, A. & AHSAN, N. (2002) Impaired endothelium-mediated vasodilation in heart failure: clinical evidence and the potential for therapy. Journal of Cardiac Failure 8, 15-20
14. ETTINGER, S. J., BENITZ, A. M., ERICSSON, G. F., CIFELLI, S. & JERNIGAN, A. D. (1998) Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. Journal of the American Veterinary Medical Association 213, 1573-1577
15. FREEMAN, L. M., RUSH, J. E., KEHAYIAS, J. J., ROSS, J. N. JR., MEYDANI, S. N., BROWN, D. J., DOLNIKOWSKI, G. G., MARMOR, B. N., WHITE, M. E., DINARELLO, C. A. & ROUBENOFF, R. (1998) Nutritional alternations and the effect of fish oil supplementation in dogs with heart failure. Journal of Veterinary Internal Medicine 12, 440-448
16. GHEORGHIADE, M., BENATAR, D., KONSTAM, M. A., STOUKIDES, C. A., & BONOW, R. O. (1997) Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials. American Journal of Cardiology 80, 14H-27H
17. GOLDSMITH, S. R., FRANCIS, G. S. & COWLEY, A. W. JR. (1986) Arginine vasopressin and the renal response to water loading in congestive heart failure. American Journal of Cardiology 58, 295-299
18. HJALMARSON, A. (2000). Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter? Basic Research in Cardiology 95, 141-145
19. IMPROVE STUDY (1995) Acute and short-term hemodynamic, echocardiographic and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of Invasive Multicenter PROspective Veterinary Evaluation of Enalapril. Journal of Veterinary Internal Medicine 9, 234-242
20. JOHNSON, W., OMLAND, T., HALL, C., LUCAS, C., MYKING, O. L., COLLINS, C., PFEFFER, M., ROULEAU, J. & STEVENSON L. W. (2002) Neurohormonal acitivation rapidly decreases after intravenous therapy with diuretics and vasodilators for Class IV heart failure. Journal of the American College of Cardiology 39, 1623-1629
21. KITAGAWA, H, WAKAMIYA, H., KITOH, K., KUWAHARA, Y., OHBA, Y., ISAJI, M., IWASAKI, T., NAKANO, M. & SASAKI, Y. (1997) Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency. Journal of Veterinary Medical Science 59, 513-520
22. KJAER, A. & HESSE, B. (2001) Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clinical Physiology 21, 661-672
23. KONERMANN, M., ALTMANN, C., LASCHEWSKI, F., JOSEPHS, W., ODENTHAL, H J., HORSTMANN, E. & SANNER, B. (1998) Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction. Clinical Cardiology 21, 277-285
24. KVART, C., HAGGSTROM, J., PEDERSEN, H. D., HANSSON, K., ERIKSSON, A., JARVINEN, A., TIDHOLM, A, BSENKO, K., AHLGREN, E., ILVES, M., ABLAD, B., FALK, T., BJERKAS, E., GUNDLER, S., LORD, P., WEGELAND, G., ADOLFSSON, E. & CORFITZEN, J. (2002) Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. Journal of Veterinary Internal Medicine 16, 80-88
25. LOMBARD, C. W. (2000) Clinical experience with pimobendan. Proceedings of The Veterinary Cardiovascular Society April meeting. Birmingham. pp 16-17
26. LUIS FUENTES, V., CORCORAN, B., FRENCH, A., SCHOBER, K. E., KLEEMANN, R. & JUSTUS, C. (2002) A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy. Journal of Veterinary Internal Medicine 16, 255-261
27. MERIT-HF STUDY (1999) Effect of metroprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure. Lancet 353, 2001-2007
28. METRA, M., GIUBBINI, R., NODARI, S., BOLDI, E., MODENA, G. M. & DEI CAS, L. (2000) Differential effects of β-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 102, 546-551
29. OLIVIER, N. B., KUTUS, S. M., BEALS, S., HANSON, B. & WINDRAM, S. (2000) Short-term effects of ecadotril in dogs with induced congestive heart failure. American Journal of Veterinary Research 61, 333-338
30. PACKER, M. (1992) Pathophysiology of chronic heart failure. Lancet 340, 88-92
31. PACKER, M. (2001) Current role of beta-adrenergic blockers in the management of chronic heart failure. American Journal of Medicine 110, 81S-94S
32. PARKER WARD, R. & ANDERSON, A. S. (2001) Slowing the progression of CHF. drug therapy to correct neurohormonal abnormalities. Postgraduate Medicine 109, 36-45
33. PICO STUDY (1996) Effects of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure Trial (PICO). Heart 76, 223-231
34. PITT, B., POOLE-WILSON, P. A., SEGAL, R., MARTINEZ, F. A., DICKSTEIN, K., CAMM, A. J., KONSTAM, M. A., RIEGGER, G., KLINGER, G. H., NEATON, J., SHARMA, D. & THIYAGARAJAN, B. (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the losartan heart failure survival study ELITE II. Lancet 355, 1582-1587
35. PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J. & WITTES, J. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. New England Journal of Medicine 341, 709-717
36. RAASCH, W., DENDORFER, A., BALL, B. & DOMINIAK, P. (1999) The lipophilic properties of angiotensin I-converting enzyme inhibitors do not influence their diffusion through cultured endothelium. Japanese Journal of Pharmacology 81, 346-352
37. ROULEAU, J. L., PFEFFER, M A., STEWART, D. J., ISAAC, D., SESTIER, F., KERUT, E. K., PORTER, C. B., PROULX, G., QIAN, C. & BLOCK, A. J. (2000) Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet 356, 615-620
38. SILVER, M A., HORTON, D P., GHALI, J. K. & ELKAYAM, U. (2002) Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. Journal of the American College of Cardiology 39, 798-803
39. SMITH, T. W. (1993) Digoxin in heart failure. New England Journal of Medicine 329, 51-53
40. SUTSCH, G., KIOWSKI, W., YAN, X. W., HUNZIKER, P., CHRISTEN, S., STROBEL, W., KIM, J. H., RICKENBACKER, P. & BERTEL, O. (1998) Short term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation 98, 2262-2268
41. URETSKY, B. F., YOUNG, J. B., SHAHIDI, F. E., YELLEN, L. G., HARRISON, M. C. & KING JOLLY, M. (1993) Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial. Journal of the American College of Cardiology 22, 955-962